Given the recurrent downregulation of BRD9 expression due to disrupted mRNA splicing of BRD9 in MDS patients16–18, we hypothesized that BRD9 may play an important role in the hematopoietic system in vivo. The gene discussed is BRD9; the disease is myelodysplastic syndrome.